跳至主要内容
临床试验/NCT06158555
NCT06158555招募中不适用

Targeted Perfusion Based Haemodynamic Management in Critically Ill Patients Using Urethral Perfusion - a Pilot Study

King's College Hospital NHS Trust1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2023年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
30
试验地点
1
主要终点
Change to Urethral Perfusion Index

研究概览

简要总结

To assess the safety and feasibility of the IKORUS device in critically ill patients and to gather exploratory data on haemodynamic coherence

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Within 24 h of ICU admission
  • Predicted length of ICU stay at least 5 days
  • Receiving >0.1 mcg/kg/min of noradrenaline at time of study enrolment

排除标准

  • Palliative treatment intent
  • Contra indication to urethral catheterisation or complication during previous urethral catheter insertion
  • Contraindication to fluid or vasopressor challenges in the opinion of the attending clinician

研究组 & 干预措施

Single Arm

Experimental

Patients will receive fluid and vasopressor challenges and the macro and microvascular responses will be recorded using the IKORUS monitor alongside conventional haemodynamic monitoring

干预措施: 250 ML NaCl 4.5 MG/ML Injection (Drug)

结局指标

主要结局

Change to Urethral Perfusion Index

时间窗: 5 minutes after fluid challenge administration

次要结局

未报告次要终点

研究者

发起方
King's College Hospital NHS Trust
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验